NDA/BLA Submission Strategy & Timeline
Executive Executive Life Sciences
The prompt
$18
Why this works
Strategic planning optimizes NDA timeline and reduces deficiency likelihood.
Risks & review
Phase 3 enrollment delays push submission back. NDA deficiencies can extend review by 6-12 months. Priority review designation is not guaranteed.